Download Files:
PDE1-IN-2
$180 – $2,520
Products Details
Product Description
– PDE1-IN-2 is a PDE1 inhibitor extracted from patent WO2016/55618 A1, example 31. PDE1-IN-2 has IC50 values of 6 nM, 140 nM and 164 nM for PDE1C, PDE1B and PDE1A, respectvely. PDE1-IN-2 is developed for the research of neurodegenerative disorders and psychiatric disorders[1].
Web ID
– HY-101490
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C16H21BrN4O2
References
– [1]Jan Kehler, et al. Triazolopyrazinones as pde1 inhibitors. WO2016055618A1.
CAS Number
– 1904611-63-7
Molecular Weight
– 381.27
Compound Purity
– 98.0
SMILES
– O=C1C2=NN=C(C3CCOCC3)N2C=C(Br)N1CC4CCCC4
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 25 mg/mL (ultrasonic)
Target
– Phosphodiesterase (PDE)
Isoform
– PDE1
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
